ISIS PHARMACEUTICALS INC.;EXCALIARD PHARMACEUTICALS INC.
发明人:
DEAN, NICHOLAS M.,FOULKES, J. GORDON,O'DONNELL, NIALL,BENNETT, C. FRANK,FREIER, SUSAN M.
申请号：
CA2733262
公开号：
CA2733262C
申请日:
2009.08.25
申请国别(地区):
CA
年份:
2019
代理人:
摘要：
This invention provides compounds which comprise modified oligonucleotidescapable of inhibitory expression ofconnective tissue growth factor and composition containing same as well asmethods of treating hyperprolific disorders and fibroticdiseases, and of reducing scarring resulting from wound healing using suchcompounds.
